These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3208301)

  • 21. [Adverse effects and drug interactions].
    Perlík F
    Cas Lek Cesk; 2004; 143(2):110-3. PubMed ID: 15077574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Status of side effects. 1. Background and current status].
    Lunde PK; Myhr K
    Tidsskr Nor Laegeforen; 1989 Nov; 109(31):3223-4. PubMed ID: 2595688
    [No Abstract]   [Full Text] [Related]  

  • 23. Monitoring for adverse drug events.
    Kennedy DL; Goldman SA
    Am Fam Physician; 1997 Nov; 56(7):1718, 1721. PubMed ID: 9371003
    [No Abstract]   [Full Text] [Related]  

  • 24. [Adverse effects of drugs in old people. Evaluation of cases received for a year at the French Association of Drug Monitoring Centers].
    Lavarenne J; Dumas R; Cayrol C
    Therapie; 1983; 38(5):485-93. PubMed ID: 6670071
    [No Abstract]   [Full Text] [Related]  

  • 25. Monitoring adverse drug reactions in the postmarketing phase.
    Hoigné R; Hottinger S
    Pharm Acta Helv; 1988; 63(1):2-12. PubMed ID: 3283774
    [No Abstract]   [Full Text] [Related]  

  • 26. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.
    Meijer WM; Cornel MC; Dolk H; de Walle HE; Armstrong NC; de Jong-van den Berg LT;
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):675-82. PubMed ID: 16761260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A literature review of adverse drug reaction reports. Adverse drug effects can have genetical background].
    Rane A
    Lakartidningen; 2002 May; 99(20):2266-7. PubMed ID: 12082942
    [No Abstract]   [Full Text] [Related]  

  • 28. [Assessment of the severity and cost of adverse drug effects recorded at the Paris-Fernand Widal Drug Monitoring Center during 2 monthly periods].
    Castot A; Lagier G; Merigot P; de Crémoux P; Efthymiou ML
    Therapie; 1987; 42(4):365-7. PubMed ID: 3686469
    [No Abstract]   [Full Text] [Related]  

  • 29. Medicines and malformations.
    McQueen EG
    N Z Med J; 1982 Apr; 95(705):241. PubMed ID: 6953363
    [No Abstract]   [Full Text] [Related]  

  • 30. Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems.
    Glasser SP; Salas M; Delzell E
    J Clin Pharmacol; 2007 Sep; 47(9):1074-86. PubMed ID: 17766697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Methods of adverse drug reactions monitoring. II. Frequencies estimations (author's transl)].
    Spriet-Pourra C; Spriet A; Soubrie C; Simon P
    Therapie; 1982; 37(1):13-22. PubMed ID: 7089914
    [No Abstract]   [Full Text] [Related]  

  • 32. [Contribution to the problem of providing information on drugs].
    Navrátil K
    Cesk Farm; 1965 Aug; 14(6):273-5. PubMed ID: 5852316
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fatal drug adverse effects].
    Reseland S
    Tidsskr Nor Laegeforen; 2005 Mar; 125(6):786. PubMed ID: 15776090
    [No Abstract]   [Full Text] [Related]  

  • 34. Failure to recognize adverse drug reactions despite warnings.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1999 Mar; 18(1):1-3. PubMed ID: 10401518
    [No Abstract]   [Full Text] [Related]  

  • 35. Adverse drug reactions--when is an adverse drug reaction not an adverse drug reaction?
    Leber P
    Psychopharmacol Bull; 1982 Apr; 18(2):6-9. PubMed ID: 7051080
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug-eruptions].
    Thielen AM; Toutous-Trellu L; Desmeules J
    Rev Med Suisse; 2008 Jul; 4(165):1671-5. PubMed ID: 18767294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Most adverse drug events unreported: take these steps.
    Hosp Peer Rev; 2007 Oct; 32(10):143-5. PubMed ID: 17957885
    [No Abstract]   [Full Text] [Related]  

  • 38. [Critical analysis of the adverse effects reported to the Paris-Fernand Widal Drug Monitoring Center in a 2-month period].
    Castot A; Carlier P; Lagier G; Elmalem J; Vincens M; Efthymiou M
    Therapie; 1986; 41(5):375-7. PubMed ID: 3810528
    [No Abstract]   [Full Text] [Related]  

  • 39. [Increased significance of adverse effects of drugs--a threat to the industry].
    Werkö L
    Lakartidningen; 2004 Dec; 101(50):4134-6. PubMed ID: 15631270
    [No Abstract]   [Full Text] [Related]  

  • 40. [Side effects of drugs leading to hospitalization in emergency medical departments. How good is the reporting system?].
    Laake K; Kramer S; Nordal A; Borchgrevink CF
    Tidsskr Nor Laegeforen; 1985 Sep; 105(26):1792-5. PubMed ID: 4060128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.